Glenmede Trust’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $338M | Sell |
1,382,668
-20,653
| -1% | -$4.81M | 1.66% | 7 |
|
|
2025
Q4 | $290M | Buy |
+1,403,321
| New | +$278M | 1.38% | 12 |
|
|
2025
Q1 | $235M | Sell |
1,416,237
-20,087
| -1% | -$3.14M | 1.26% | 9 |
|
|
2024
Q4 | $208M | Sell |
1,436,324
-226,565
| -14% | -$35.1M | 1.06% | 13 |
|
|
2024
Q3 | $269M | Buy |
1,662,889
+49,891
| +3% | +$7.95M | 1.29% | 8 |
|
|
2024
Q2 | $236M | Buy |
1,612,998
+33,420
| +2% | +$4.97M | 1.2% | 11 |
|
|
2024
Q1 | $250M | Sell |
1,579,578
-72,690
| -4% | -$11.6M | 1.25% | 9 |
|
|
2023
Q4 | $259M | Sell |
1,652,268
-9,361
| -0.6% | -$1.44M | 1.34% | 6 |
|
|
2023
Q3 | $259M | Sell |
1,661,629
-34,378
| -2% | -$5.67M | 1.48% | 6 |
|
|
2023
Q2 | $263M | Hold |
1,696,007
| – | – | 1.49% | 6 |
|
|
2023
Q1 | $263M | Sell |
1,696,007
-20,217
| -1% | -$3.26M | 1.49% | 6 |
|
|
2022
Q4 | $303M | Sell |
1,716,224
-19,196
| -1% | -$3.31M | 1.78% | 6 |
|
|
2022
Q3 | $283M | Buy |
1,735,420
+4,196
| +0.2% | +$710K | 1.79% | 6 |
|
|
2022
Q2 | $307M | Sell |
1,731,224
-30,278
| -2% | -$5.39M | 1.8% | 6 |
|
|
2022
Q1 | $312M | Sell |
1,761,502
-145,733
| -8% | -$24.8M | 1.53% | 6 |
|
|
2021
Q4 | $326M | Sell |
1,907,235
-11,182
| -0.6% | -$1.83M | 1.55% | 6 |
|
|
2021
Q3 | $310M | Sell |
1,918,417
-186,667
| -9% | -$31.8M | 1.61% | 6 |
|
|
2021
Q2 | $347M | Sell |
2,105,084
-151,402
| -7% | -$25.1M | 1.79% | 5 |
|
|
2021
Q1 | $371M | Buy |
2,256,486
+178,451
| +9% | +$28.9M | 2% | 5 |
|
|
2020
Q4 | $327M | Buy |
2,078,035
+124,703
| +6% | +$18.4M | 1.8% | 4 |
|
|
2020
Q3 | $291M | Buy |
1,953,332
+148,594
| +8% | +$22M | 1.74% | 4 |
|
|
2020
Q2 | $254M | Sell |
1,804,738
-52,464
| -3% | -$7.65M | 1.55% | 4 |
|
|
2020
Q1 | $271M | Hold |
1,857,202
| – | – | 1.24% | 3 |
|
|
2019
Q4 | $271M | Sell |
1,857,202
-45,333
| -2% | -$6.15M | 1.24% | 3 |
|
|
2019
Q3 | $246K | Sell |
1,902,535
-113,864
| -6% | -$15M | 1.13% | 6 |
|
|
2019
Q2 | $281K | Buy |
2,016,399
+15,355
| +0.8% | +$2.13M | 1.23% | 4 |
|
|
2019
Q1 | $280K | Sell |
2,001,044
-23,323
| -1% | -$3.12M | 1.27% | 4 |
|
|
2018
Q4 | $261K | Sell |
2,024,367
-12,617
| -0.6% | -$1.76M | 1.27% | 4 |
|
|
2018
Q3 | $281M | Sell |
2,036,984
-6,048,824
| -75% | -$804M | 1.13% | 8 |
|
|
2018
Q2 | $981M | Sell |
8,085,808
-792,882
| -9% | -$98.9M | 4.34% | 1 |
|
|
2018
Q1 | $1.24B | Hold |
8,878,690
| – | – | 5.17% | 1 |
|
|
2017
Q4 | $1.24B | Sell |
8,878,690
-142,119
| -2% | -$19.8M | 5.17% | 1 |
|
|
2017
Q3 | $1.17B | Sell |
9,020,809
-49,713
| -0.5% | -$6.59M | 5.14% | 1 |
|
|
2017
Q2 | $1.13B | Hold |
9,070,522
| – | – | 5.4% | 1 |
|
|
2017
Q1 | $1.13B | Buy |
9,070,522
+6,682,389
| +280% | +$798M | 5.4% | 1 |
|
|
2016
Q4 | $275M | Sell |
2,388,133
-113,155
| -5% | -$13.1M | 1.5% | 2 |
|
|
2016
Q3 | $295M | Sell |
2,501,288
-85,655
| -3% | -$10.4M | 1.66% | 1 |
|
|
2016
Q2 | $314M | Sell |
2,586,943
-43,441
| -2% | -$4.94M | 1.9% | 1 |
|
|
2016
Q1 | $285M | Sell |
2,630,384
-34,758
| -1% | -$3.6M | 1.84% | 1 |
|
|
2015
Q4 | $274M | Sell |
2,665,142
-72,883
| -3% | -$7.33M | 1.87% | 1 |
|
|
2015
Q3 | $256M | Buy |
2,738,025
+331,985
| +14% | +$32.1M | 1.87% | 1 |
|
|
2015
Q2 | $234M | Sell |
2,406,040
-48,719
| -2% | -$4.88M | 1.69% | 2 |
|
|
2015
Q1 | $247M | Buy |
2,454,759
+13,192
| +0.5% | +$1.34M | 1.8% | 2 |
|
|
2014
Q4 | $255M | Buy |
2,441,567
+70,138
| +3% | +$7.39M | 2% | 1 |
|
|
2014
Q3 | $253M | Sell |
2,371,429
-55,178
| -2% | -$5.72M | 2.22% | 1 |
|
|
2014
Q2 | $254M | Sell |
2,426,607
-37,574
| -2% | -$3.8M | 2.28% | 2 |
|
|
2014
Q1 | $242M | Sell |
2,464,181
-122,552
| -5% | -$11.4M | 2.25% | 2 |
|
|
2013
Q4 | $237M | Sell |
2,586,733
-82,612
| -3% | -$7.61M | 2.42% | 2 |
|
|
2013
Q3 | $117M | Sell |
2,669,345
-33,083
| -1% | -$2.97M | 1.39% | 5 |
|
|
2013
Q2 | $232M | Buy |
+2,702,428
| New | +$229M | 2.89% | 2 |
|
Other funds holding JNJ
VCM
VPM
Glenmede Trust's JNJ Position: Q1 2026 in Review
Glenmede Trust reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q1 2026, selling an estimated $4.81M and leaving 1,382,668 shares worth $338M. The position accounts for 1.66% of the portfolio, ranked #7.
Glenmede Trust first reported a position in JNJ in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.24B in Q1 2018. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Glenmede Trust held 1,382,668 shares of Johnson & Johnson worth $338M as of Q1 2026.
- Glenmede Trust sold 20,653 Johnson & Johnson shares in Q1 2026, an estimated $4.81M.
- Johnson & Johnson made up 1.66% of Glenmede Trust's portfolio in Q1 2026, its #7 holding.
- Glenmede Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 50 quarters since.
- Glenmede Trust's Johnson & Johnson position peaked at $1.24B in Q1 2018.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.